InnateDB Protein
|
IDBP-69242.5
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
FXN
|
Protein Name
|
frataxin
|
Synonyms
|
CyaY; FA; FARR; FRDA; X25;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000366482
|
InnateDB Gene
|
IDBG-69240 (FXN)
|
Protein Structure
|
|
Function |
Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe(2+) to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe(2+) to Fe(3+); the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. Modulates the RNA-binding activity of ACO1. {ECO:0000269PubMed:12785837, ECO:0000269PubMed:15247478, ECO:0000269PubMed:15641778, ECO:0000269PubMed:16239244, ECO:0000269PubMed:16608849, ECO:0000269PubMed:20053667}.
|
Subcellular Localization |
Cytoplasm. Mitochondrion. Note=PubMed:18725397 reports localization exclusively in mitochondria.
|
Disease Associations |
Friedreich ataxia (FRDA) [MIM:229300]: Autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region. {ECO:0000269PubMed:10732799, ECO:0000269PubMed:10874325, ECO:0000269PubMed:9150176, ECO:0000269PubMed:9779809, ECO:0000269PubMed:9989622, ECO:0000269Ref.34, ECO:0000269Ref.7, ECO:0000269Ref.8}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Expressed in the heart, peripheral blood lymphocytes and dermal fibroblasts. {ECO:0000269PubMed:17468497}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 7 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
7
[view]
|
Protein-Protein |
6
[view]
|
Protein-DNA |
1
[view]
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR002908
Frataxin/CyaY
IPR017789
Frataxin
|
PFAM |
PF01491
|
PRINTS |
PR00904
|
PIRSF |
|
SMART |
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q16595
|
PhosphoSite |
PhosphoSite-Q16595
|
TrEMBL |
C9JAX1
|
UniProt Splice Variant |
|
Entrez Gene |
2395
|
UniGene |
|
RefSeq |
NP_000135
|
HUGO |
HGNC:3951
|
OMIM |
606829
|
CCDS |
CCDS6626
|
HPRD |
06013
|
IMGT |
|
EMBL |
AF028240
AL162730
BC023633
BC048097
U43747
U43748
U43749
U43750
U43751
U43752
U43753
U93173
Y13751
|
GenPept |
AAA98508
AAA98509
AAA98510
AAB84047
AAD00734
AAH23633
AAH48097
CAA74077
CAH71829
|
|
|